Arrowpoint Investment Partners Singapore Pte. Ltd. Invests $1.23 Million in Danaher Corporation $DHR

Arrowpoint Investment Partners Singapore Pte. Ltd. bought a new stake in Danaher Corporation (NYSE:DHR) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 5,368 shares of the conglomerate’s stock, valued at approximately $1,229,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Enterprise Financial Services Corp increased its holdings in shares of Danaher by 1.4% in the fourth quarter. Enterprise Financial Services Corp now owns 3,219 shares of the conglomerate’s stock valued at $737,000 after purchasing an additional 46 shares during the last quarter. Kennebec Savings Bank boosted its stake in Danaher by 1.4% during the fourth quarter. Kennebec Savings Bank now owns 3,348 shares of the conglomerate’s stock worth $766,000 after buying an additional 46 shares during the last quarter. Revolve Wealth Partners LLC grew its holdings in Danaher by 2.6% in the 4th quarter. Revolve Wealth Partners LLC now owns 1,870 shares of the conglomerate’s stock valued at $428,000 after buying an additional 47 shares in the last quarter. High Note Wealth LLC grew its holdings in Danaher by 19.2% in the 4th quarter. High Note Wealth LLC now owns 292 shares of the conglomerate’s stock valued at $67,000 after buying an additional 47 shares in the last quarter. Finally, Kestra Private Wealth Services LLC increased its stake in shares of Danaher by 0.3% in the 3rd quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate’s stock worth $3,057,000 after acquiring an additional 48 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Up 4.9%

NYSE:DHR opened at $186.86 on Friday. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. The stock’s fifty day moving average is $181.34 and its two-hundred day moving average is $206.35. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The stock has a market capitalization of $132.25 billion, a price-to-earnings ratio of 36.14, a price-to-earnings-growth ratio of 2.38 and a beta of 0.81.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. The business had revenue of $5.95 billion during the quarter, compared to analysts’ expectations of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The company’s revenue was up 3.7% on a year-over-year basis. During the same period in the previous year, the firm posted $1.88 earnings per share. Research analysts anticipate that Danaher Corporation will post 8.43 EPS for the current year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s payout ratio is currently 30.95%.

Analyst Ratings Changes

Several research analysts have recently weighed in on the stock. TD Cowen lowered their price target on shares of Danaher from $245.00 to $240.00 and set a “buy” rating on the stock in a research report on Wednesday, April 22nd. The Goldman Sachs Group cut their price objective on shares of Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research report on Monday, April 13th. Weiss Ratings reiterated a “hold (c)” rating on shares of Danaher in a report on Friday, March 27th. HSBC dropped their price target on shares of Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a research note on Wednesday. Finally, Wolfe Research downgraded shares of Danaher from an “outperform” rating to a “peer perform” rating in a report on Monday. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat, Danaher presently has a consensus rating of “Moderate Buy” and a consensus target price of $235.14.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.